Clinicopathological Features, Recurrence Patterns, and Prognosis of Pancreatic Adenocarcinoma with Normal Serum CA19-9. A Consecutive Series of 154 Cases from ... View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

2019-04-03

AUTHORS

Yajie Zhao, Chengfeng Wang

ABSTRACT

BACKGROUND: Serum levels of CA19-9 correlate with recurrence and survival in patients with pancreatic adenocarcinoma; however, little is known about the features and prognosis of pancreatic adenocarcinoma with normal CA19-9 levels. METHOD: Patients with pancreatic adenocarcinoma (n = 806) were split into two groups with normal (≤ 37 U/mL) and elevated (> 37 U/mL) CA19-9. The clinicopathological features, survival, and recurrence patterns were compared between two groups. We also sought to identify factors that best predicted prognosis in pancreatic adenocarcinoma with normal CA19-9 levels, to assist in the selection of the most effective adjuvant treatment. RESULTS: Pancreatic adenocarcinoma with normal CA19-9 were less likely to have lymph node metastasis, angiolymphatic invasion, intrapancreatic neural invasion, anterior serosal invasion, and invasion of the surrounding tissue/organ (distal bile duct, duodenum, or splenic artery or vein). Following propensity-score matching, pancreatic adenocarcinoma with normal CA19-9 levels (≤ 37 U/ml) were associated with significantly superior overall survival following resection. Moreover, the CA19-9 ≤ 37 U/mL group demonstrated a significantly lower rate of local recurrence (35.57% vs. 52.35%, p = 0.004), distant recurrence (42.95% vs. 60.4%, p = 0.003), and mixed recurrence (5.37% vs. 29.53%, p < 0.000) compared with the CA19-9 > 37 U/mL group. Multivariate analysis suggested that angiolymphatic invasion, lymph node metastases, and tumor size > 3 cm were independent prognostic factors for pancreatic adenocarcinoma with normal CA19-9. Survival analyses suggested that post-op chemoradiotherapy or chemotherapy were associated with more favorable outcomes. CONCLUSIONS: Pancreatic adenocarcinoma with normal pretreatment CA19-9 levels (≤ 37 U/ml) were characterized by better biological characteristics, reduced rates of recurrence, and longer overall survival. Moreover, optimal adjuvant therapy should be performed after surgery. More... »

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/s11605-019-04209-w

DOI

http://dx.doi.org/10.1007/s11605-019-04209-w

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1113182458

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/30945087


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1112", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Oncology and Carcinogenesis", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Peking Union Medical College Hospital", 
          "id": "https://www.grid.ac/institutes/grid.413106.1", 
          "name": [
            "Department of Pancreatic and Gastric surgery, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100021, China."
          ], 
          "type": "Organization"
        }, 
        "familyName": "Zhao", 
        "givenName": "Yajie", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Peking Union Medical College Hospital", 
          "id": "https://www.grid.ac/institutes/grid.413106.1", 
          "name": [
            "Department of Pancreatic and Gastric surgery, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100021, China. pcrsurgery@163.com."
          ], 
          "type": "Organization"
        }, 
        "familyName": "Wang", 
        "givenName": "Chengfeng", 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "https://doi.org/10.1016/j.canlet.2006.01.004", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1004298094"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/bf01307186", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1004947456", 
          "https://doi.org/10.1007/bf01307186"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/bf01307186", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1004947456", 
          "https://doi.org/10.1007/bf01307186"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1111/j.1349-7006.2004.tb03219.x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1005603340"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1111/j.1349-7006.2004.tb03219.x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1005603340"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1245/s10434-009-0415-7", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1020237627", 
          "https://doi.org/10.1245/s10434-009-0415-7"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1158/1078-0432.ccr-05-0292", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1024102953"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/1097-0142(19860215)57:4<779::aid-cncr2820570417>3.0.co;2-c", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1026501922"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/bf01542654", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1027172486", 
          "https://doi.org/10.1007/bf01542654"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/bf01542654", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1027172486", 
          "https://doi.org/10.1007/bf01542654"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0140-6736(95)92136-2", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1027380285"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0140-6736(95)92136-2", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1027380285"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1159/000140961", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1029571837"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/sj.bjc.6600048", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1030449453", 
          "https://doi.org/10.1038/sj.bjc.6600048"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/sj.bjc.6600048", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1030449453", 
          "https://doi.org/10.1038/sj.bjc.6600048"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.3892/ijo.17.1.55", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1071511386"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1076864449", 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1078248591", 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1082173685", 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1083377216", 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.3390/cancers10020036", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1100724221"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2019-04-03", 
    "datePublishedReg": "2019-04-03", 
    "description": "BACKGROUND: Serum levels of CA19-9 correlate with recurrence and survival in patients with pancreatic adenocarcinoma; however, little is known about the features and prognosis of pancreatic adenocarcinoma with normal CA19-9 levels.\nMETHOD: Patients with pancreatic adenocarcinoma (n\u2009=\u2009806) were split into two groups with normal (\u2264\u200937\u00a0U/mL) and elevated (>\u200937\u00a0U/mL) CA19-9. The clinicopathological features, survival, and recurrence patterns were compared between two groups. We also sought to identify factors that best predicted prognosis in pancreatic adenocarcinoma with normal CA19-9 levels, to assist in the selection of the most effective adjuvant treatment.\nRESULTS: Pancreatic adenocarcinoma with normal CA19-9 were less likely to have lymph node metastasis, angiolymphatic invasion, intrapancreatic neural invasion, anterior serosal invasion, and invasion of the surrounding tissue/organ (distal bile duct, duodenum, or splenic artery or vein). Following propensity-score matching, pancreatic adenocarcinoma with normal CA19-9 levels (\u2264\u200937\u00a0U/ml) were associated with significantly superior overall survival following resection. Moreover, the CA19-9\u2009\u2264\u200937\u00a0U/mL group demonstrated a significantly lower rate of local recurrence (35.57% vs. 52.35%, p\u2009=\u20090.004), distant recurrence (42.95% vs. 60.4%, p\u2009=\u20090.003), and mixed recurrence (5.37% vs. 29.53%, p\u2009<\u20090.000) compared with the CA19-9\u2009>\u200937\u00a0U/mL group. Multivariate analysis suggested that angiolymphatic invasion, lymph node metastases, and tumor size >\u20093\u00a0cm were independent prognostic factors for pancreatic adenocarcinoma with normal CA19-9. Survival analyses suggested that post-op chemoradiotherapy or chemotherapy were associated with more favorable outcomes.\nCONCLUSIONS: Pancreatic adenocarcinoma with normal pretreatment CA19-9 levels (\u2264 37\u00a0U/ml) were characterized by better biological characteristics, reduced rates of recurrence, and longer overall survival. Moreover, optimal adjuvant therapy should be performed after surgery.", 
    "genre": "research_article", 
    "id": "sg:pub.10.1007/s11605-019-04209-w", 
    "inLanguage": [
      "en"
    ], 
    "isAccessibleForFree": false, 
    "isPartOf": [
      {
        "id": "sg:journal.1116755", 
        "issn": [
          "1091-255X", 
          "1873-4626"
        ], 
        "name": "Journal of Gastrointestinal Surgery", 
        "type": "Periodical"
      }
    ], 
    "name": "Clinicopathological Features, Recurrence Patterns, and Prognosis of Pancreatic Adenocarcinoma with Normal Serum CA19-9. A Consecutive Series of 154 Cases from a Single Institute.", 
    "productId": [
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "30945087"
        ]
      }, 
      {
        "name": "nlm_unique_id", 
        "type": "PropertyValue", 
        "value": [
          "9706084"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/s11605-019-04209-w"
        ]
      }, 
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1113182458"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1007/s11605-019-04209-w", 
      "https://app.dimensions.ai/details/publication/pub.1113182458"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2019-04-11T14:01", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-uberresearch-data-dimensions-target-20181106-alternative/cleanup/v134/2549eaecd7973599484d7c17b260dba0a4ecb94b/merge/v9/a6c9fde33151104705d4d7ff012ea9563521a3ce/jats-lookup/v90/0000000371_0000000371/records_130829_00000007.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "http://link.springer.com/10.1007/s11605-019-04209-w"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/s11605-019-04209-w'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/s11605-019-04209-w'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/s11605-019-04209-w'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/s11605-019-04209-w'


 

This table displays all metadata directly associated to this object as RDF triples.

112 TRIPLES      20 PREDICATES      40 URIs      16 LITERALS      6 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/s11605-019-04209-w schema:about anzsrc-for:11
2 anzsrc-for:1112
3 schema:author N253023d0330049209c7094aa221c1b8f
4 schema:citation sg:pub.10.1007/bf01307186
5 sg:pub.10.1007/bf01542654
6 sg:pub.10.1038/sj.bjc.6600048
7 sg:pub.10.1245/s10434-009-0415-7
8 https://app.dimensions.ai/details/publication/pub.1076864449
9 https://app.dimensions.ai/details/publication/pub.1078248591
10 https://app.dimensions.ai/details/publication/pub.1082173685
11 https://app.dimensions.ai/details/publication/pub.1083377216
12 https://doi.org/10.1002/1097-0142(19860215)57:4<779::aid-cncr2820570417>3.0.co;2-c
13 https://doi.org/10.1016/j.canlet.2006.01.004
14 https://doi.org/10.1016/s0140-6736(95)92136-2
15 https://doi.org/10.1111/j.1349-7006.2004.tb03219.x
16 https://doi.org/10.1158/1078-0432.ccr-05-0292
17 https://doi.org/10.1159/000140961
18 https://doi.org/10.3390/cancers10020036
19 https://doi.org/10.3892/ijo.17.1.55
20 schema:datePublished 2019-04-03
21 schema:datePublishedReg 2019-04-03
22 schema:description BACKGROUND: Serum levels of CA19-9 correlate with recurrence and survival in patients with pancreatic adenocarcinoma; however, little is known about the features and prognosis of pancreatic adenocarcinoma with normal CA19-9 levels. METHOD: Patients with pancreatic adenocarcinoma (n = 806) were split into two groups with normal (≤ 37 U/mL) and elevated (> 37 U/mL) CA19-9. The clinicopathological features, survival, and recurrence patterns were compared between two groups. We also sought to identify factors that best predicted prognosis in pancreatic adenocarcinoma with normal CA19-9 levels, to assist in the selection of the most effective adjuvant treatment. RESULTS: Pancreatic adenocarcinoma with normal CA19-9 were less likely to have lymph node metastasis, angiolymphatic invasion, intrapancreatic neural invasion, anterior serosal invasion, and invasion of the surrounding tissue/organ (distal bile duct, duodenum, or splenic artery or vein). Following propensity-score matching, pancreatic adenocarcinoma with normal CA19-9 levels (≤ 37 U/ml) were associated with significantly superior overall survival following resection. Moreover, the CA19-9 ≤ 37 U/mL group demonstrated a significantly lower rate of local recurrence (35.57% vs. 52.35%, p = 0.004), distant recurrence (42.95% vs. 60.4%, p = 0.003), and mixed recurrence (5.37% vs. 29.53%, p < 0.000) compared with the CA19-9 > 37 U/mL group. Multivariate analysis suggested that angiolymphatic invasion, lymph node metastases, and tumor size > 3 cm were independent prognostic factors for pancreatic adenocarcinoma with normal CA19-9. Survival analyses suggested that post-op chemoradiotherapy or chemotherapy were associated with more favorable outcomes. CONCLUSIONS: Pancreatic adenocarcinoma with normal pretreatment CA19-9 levels (≤ 37 U/ml) were characterized by better biological characteristics, reduced rates of recurrence, and longer overall survival. Moreover, optimal adjuvant therapy should be performed after surgery.
23 schema:genre research_article
24 schema:inLanguage en
25 schema:isAccessibleForFree false
26 schema:isPartOf sg:journal.1116755
27 schema:name Clinicopathological Features, Recurrence Patterns, and Prognosis of Pancreatic Adenocarcinoma with Normal Serum CA19-9. A Consecutive Series of 154 Cases from a Single Institute.
28 schema:productId N23205a5bb19e4bcf986318b9b9461725
29 N718644e4456f464f9a4bc33d75063d9e
30 N80f42f8ed85d48ac8628b8c8d7512933
31 N83a0bc34b8994f13862dba3ca76dd590
32 schema:sameAs https://app.dimensions.ai/details/publication/pub.1113182458
33 https://doi.org/10.1007/s11605-019-04209-w
34 schema:sdDatePublished 2019-04-11T14:01
35 schema:sdLicense https://scigraph.springernature.com/explorer/license/
36 schema:sdPublisher N24cb5739126e453cbd9a1657f31caf3d
37 schema:url http://link.springer.com/10.1007/s11605-019-04209-w
38 sgo:license sg:explorer/license/
39 sgo:sdDataset articles
40 rdf:type schema:ScholarlyArticle
41 N23205a5bb19e4bcf986318b9b9461725 schema:name pubmed_id
42 schema:value 30945087
43 rdf:type schema:PropertyValue
44 N24cb5739126e453cbd9a1657f31caf3d schema:name Springer Nature - SN SciGraph project
45 rdf:type schema:Organization
46 N253023d0330049209c7094aa221c1b8f rdf:first Ne815cbf695e94ec18dea8b6975231aaf
47 rdf:rest N69807d59dc13450099089abe1ca5d89f
48 N69807d59dc13450099089abe1ca5d89f rdf:first N84140a2c393345d5ac53b7f63db5fc45
49 rdf:rest rdf:nil
50 N718644e4456f464f9a4bc33d75063d9e schema:name doi
51 schema:value 10.1007/s11605-019-04209-w
52 rdf:type schema:PropertyValue
53 N80f42f8ed85d48ac8628b8c8d7512933 schema:name nlm_unique_id
54 schema:value 9706084
55 rdf:type schema:PropertyValue
56 N83a0bc34b8994f13862dba3ca76dd590 schema:name dimensions_id
57 schema:value pub.1113182458
58 rdf:type schema:PropertyValue
59 N84140a2c393345d5ac53b7f63db5fc45 schema:affiliation https://www.grid.ac/institutes/grid.413106.1
60 schema:familyName Wang
61 schema:givenName Chengfeng
62 rdf:type schema:Person
63 Ne815cbf695e94ec18dea8b6975231aaf schema:affiliation https://www.grid.ac/institutes/grid.413106.1
64 schema:familyName Zhao
65 schema:givenName Yajie
66 rdf:type schema:Person
67 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
68 schema:name Medical and Health Sciences
69 rdf:type schema:DefinedTerm
70 anzsrc-for:1112 schema:inDefinedTermSet anzsrc-for:
71 schema:name Oncology and Carcinogenesis
72 rdf:type schema:DefinedTerm
73 sg:journal.1116755 schema:issn 1091-255X
74 1873-4626
75 schema:name Journal of Gastrointestinal Surgery
76 rdf:type schema:Periodical
77 sg:pub.10.1007/bf01307186 schema:sameAs https://app.dimensions.ai/details/publication/pub.1004947456
78 https://doi.org/10.1007/bf01307186
79 rdf:type schema:CreativeWork
80 sg:pub.10.1007/bf01542654 schema:sameAs https://app.dimensions.ai/details/publication/pub.1027172486
81 https://doi.org/10.1007/bf01542654
82 rdf:type schema:CreativeWork
83 sg:pub.10.1038/sj.bjc.6600048 schema:sameAs https://app.dimensions.ai/details/publication/pub.1030449453
84 https://doi.org/10.1038/sj.bjc.6600048
85 rdf:type schema:CreativeWork
86 sg:pub.10.1245/s10434-009-0415-7 schema:sameAs https://app.dimensions.ai/details/publication/pub.1020237627
87 https://doi.org/10.1245/s10434-009-0415-7
88 rdf:type schema:CreativeWork
89 https://app.dimensions.ai/details/publication/pub.1076864449 schema:CreativeWork
90 https://app.dimensions.ai/details/publication/pub.1078248591 schema:CreativeWork
91 https://app.dimensions.ai/details/publication/pub.1082173685 schema:CreativeWork
92 https://app.dimensions.ai/details/publication/pub.1083377216 schema:CreativeWork
93 https://doi.org/10.1002/1097-0142(19860215)57:4<779::aid-cncr2820570417>3.0.co;2-c schema:sameAs https://app.dimensions.ai/details/publication/pub.1026501922
94 rdf:type schema:CreativeWork
95 https://doi.org/10.1016/j.canlet.2006.01.004 schema:sameAs https://app.dimensions.ai/details/publication/pub.1004298094
96 rdf:type schema:CreativeWork
97 https://doi.org/10.1016/s0140-6736(95)92136-2 schema:sameAs https://app.dimensions.ai/details/publication/pub.1027380285
98 rdf:type schema:CreativeWork
99 https://doi.org/10.1111/j.1349-7006.2004.tb03219.x schema:sameAs https://app.dimensions.ai/details/publication/pub.1005603340
100 rdf:type schema:CreativeWork
101 https://doi.org/10.1158/1078-0432.ccr-05-0292 schema:sameAs https://app.dimensions.ai/details/publication/pub.1024102953
102 rdf:type schema:CreativeWork
103 https://doi.org/10.1159/000140961 schema:sameAs https://app.dimensions.ai/details/publication/pub.1029571837
104 rdf:type schema:CreativeWork
105 https://doi.org/10.3390/cancers10020036 schema:sameAs https://app.dimensions.ai/details/publication/pub.1100724221
106 rdf:type schema:CreativeWork
107 https://doi.org/10.3892/ijo.17.1.55 schema:sameAs https://app.dimensions.ai/details/publication/pub.1071511386
108 rdf:type schema:CreativeWork
109 https://www.grid.ac/institutes/grid.413106.1 schema:alternateName Peking Union Medical College Hospital
110 schema:name Department of Pancreatic and Gastric surgery, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100021, China.
111 Department of Pancreatic and Gastric surgery, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100021, China. pcrsurgery@163.com.
112 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...